Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Open in API
Filings indexed 794 across all filing types
Latest filing 2020-04-20 Governance Information
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Satzung 2020
Governance Information Classification · 98% confidence The document is titled 'Neufassung der Satzung und Satzungsbescheinigung gemäß § 181 AktG' (New version of the Articles of Association and Certificate of Articles of Association pursuant to § 181 German Stock Corporation Act) and contains the full text of the 'SATZUNG' (Articles of Association) for Vita 34 AG, including sections on the company name, registered office, business purpose, capital, board, supervisory board, and general meetings. This document is a foundational corporate governance document, not a periodic financial report (like 10-K or IR) or a simple announcement. It directly details the company's internal rules and structure. This aligns best with Governance Information (CGR), which covers internal rules and board structure.
2020-04-20 German
Datum:31.03.2020
Annual Report Classification · 100% confidence The document is a section of the 2019 Annual Report for Vita 34 AG. It contains the 'Bericht des Aufsichtsrats' (Supervisory Board Report) and the beginning of the 'Zusammengefasster Lagebericht' (Combined Management Report). Since it includes substantive financial and operational analysis, management commentary, and governance disclosures typical of a full annual report, it is classified as an Annual Report (10-K). FY 2019
2020-03-31 German
Datum:30.03.2020
Audit Report / Information Classification · 98% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Vita 34 AG for the fiscal year ending December 31, 2019. It contains a balance sheet (Bilanz), income statement (Gewinn- und Verlustrechnung), and detailed notes (Anhang). This constitutes the core components of an annual report. Although it is a standalone financial statement document rather than a glossy annual report, it fits the definition of a 10-K (Annual Report) in the context of financial reporting filings. FY 2019
2020-03-30 German
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting the 'Notification of Major Holdings' pursuant to Article 40, Section 1 of the WpHG (German Securities Trading Act). It specifies the date the threshold was crossed (20 March 2020), the new percentage of voting rights (3.19%), and the chain of controlled undertakings. This content directly aligns with the definition of reporting changes in significant share ownership levels, which corresponds to the Major Shareholding Notification category (MRQ). Although the header mentions 'Voting Rights Announcements', the core content is the disclosure of a major holding crossing a threshold.
2020-03-26 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Voting Rights Announcements' and explicitly contains a section labeled 'Notification of Major Holdings'. It details the acquisition/disposal of shares with voting rights, crossing a threshold (3.19%), and lists the shareholder and the chain of control. This content directly corresponds to regulatory filings concerning changes in significant share ownership, which matches the definition for Major Shareholding Notification (MRQ). Although the header mentions 'Voting Rights Announcements', the core content is the disclosure of a major holding change, making MRQ the most precise fit among the provided options. It is not a general regulatory filing (RNS) because it is highly specific to share ownership thresholds.
2020-03-26 English
Vita 34 successfully concludes also fourth quarter 2019 with organic growth
Earnings Release Classification · 100% confidence The document is a news release dated March 23, 2020, announcing the financial results for the fourth quarter and the full year 2019. Key phrases include "Annual Results," specific Q4 and full-year revenue/EBITDA figures, and a forward-looking statement for 2020. This content structure—summarizing key performance indicators (KPIs) for a completed period immediately following the period's end—is characteristic of an Earnings Release (ER). Although it mentions the 'complete annual report 2019 is available for download,' the document itself is the initial announcement of the results, not the full report (10-K) or a mere announcement of publication (RPA). The length (9501 chars) is substantial enough to contain key figures, confirming it is more than just a brief announcement. Q4 2019
2020-03-23 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.